Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications



Status:Completed
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/21/2018
Start Date:June 28, 2016
End Date:November 14, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
This study is being done to determine if sending reminder text messages helps patients take
their Oral Anticancer Medication (OAMs) when they are supposed to.


Inclusion Criteria:

- Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine
service at MSK.

- Starting a new treatment regimen that includes a single oral anticancer medication

- Patients must have a mobile phone that can send and receive SMS/MMS messages and is
internet-enabled.

- Age 18 or older.

- Ability to speak and read English because we do not have the resources to translate
the text messages into other languages.

Exclusion Criteria:

- Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their
phone and is unwilling to be trained in the use of this technology.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Thomas Atkinson, PhD
Phone: 646-888-0089
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials